Generation of Micro-Particles of Proteins for Aerosol Delivery Using High Pressure Modified Carbon Dioxide

AbstractPurpose. To investigate the feasibility of using the Aerosol Solvent Extraction System (ASES) to generate microparticles of proteins suitable for aerosol delivery from aqueous-based solutions. Methods. The ASES technique using high- pressure carbon dioxide modified with ethanol was utilised for the generation of microparticles of proteins (lysozyme, albumin, insulin and recombinant human deoxyribonuclease (rhDNase)) from aqueous solutions. Particle size, morphology, size distributions and powder aerosol performance were examined. The biochemical integrity of the processed proteins was assessed by testing the level of molecular aggregation using size exclusion chromatography and by bioassay technique for lysozyme. Results. Proteins were precipitated as spherical particles ranging in size from 100 to 500 nm. The primary nano-sized particles agglomerated to form micron-sized particles during the precipitation process. The median size of the particles was a function of the operating conditions. In-vitro aerosol performance tests showed that the percent fine particle mass (< 5μm) was approximately 65%, 40% and 20% for lysozyme, albumin and insulin, respectively. Negligible loss in the monomer content or biological activity was observed for lysozyme. Insulin exhibited slight aggregation and 93% of the monomer was retained after processing. Albumin was affected by processing and only 50-75% of the monomer was retained compared with 86% in the original material. However, rhDNase was substantially denatured during processing as shown by the significantly reduced monomer content. Conclusions. Micron-sized particles of lysozyme, albumin and insulin with satisfactory inhalation performance were successfully generated from aqueous solutions using the modified ASES technique. The biochemical integrity of the processed proteins was a function of the operating conditions and the nature of the individual protein.

[1]  Jean W. Tom,et al.  Application of supercritical fluids for the production of sustained delivery devices , 1993 .

[2]  K. Taylor.  Book review: Inhalation Delivery of Therapeutic Peptides and Proteins. Adjei AL, Gupta PK, eds. Marcel Dekker, New York , 1997 .

[3]  K. Yamamoto,et al.  Conformational change of bovine serum albumin by heat treatment , 1989, Journal of protein chemistry.

[4]  S J Prestrelski,et al.  Precipitation of proteins in supercritical carbon dioxide. , 1996, Journal of pharmaceutical sciences.

[5]  R. Niven,et al.  The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation , 1996 .

[6]  G. Lim,et al.  Formation of microparticulate protein powder using a supercritical fluid antisolvent , 1993, Biotechnology and bioengineering.

[7]  Pramod K. Gupta,et al.  Inhalation Delivery of Therapeutic Peptides and Proteins , 1997 .

[8]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[9]  Peter York,et al.  Phase Behavioral Effects on Particle Formation Processes Using Supercritical Fluids , 1999, Pharmaceutical Research.

[10]  M. Paulaitis,et al.  Gas-liquid equilibrium for ethanol-water-carbon dioxide mixtures at elevated pressures , 1986 .

[11]  Jong Sung Lim,et al.  Phase equilibria for carbon dioxide-ethanol-water system at elevated pressures , 1994 .

[12]  F. Dehghani,et al.  The influence of operating conditions on the dense gas precipitation of model proteins , 2000 .

[13]  Dean W. Matson,et al.  Production of powders and films by the rapid expansion of supercritical solutions , 1987 .

[14]  R. Wiebe,et al.  Vapor Phase Composition of Carbon Dioxide-Water Mixtures at Various Temperatures and at Pressures to 700 Atmospheres , 1941 .

[15]  F. Dehghani,et al.  Extraction and separation of lanthanides using dense gas CO2 modified with tributyl phosphate and di(2-ethyl hexyl)phosphoric acid , 1996 .

[16]  T. R. Bott,et al.  The mutual solubilities of water with supercritical and liquid carbon dioxides , 1992 .

[17]  W. W. Hillstrom,et al.  Gas anti-solvent recrystallization of RDX: Formation of ultra-fine particles of a difficult-to-comminute explosive , 1992 .

[18]  Chung C. Hsu,et al.  Spray Dried Powders and Powder Blends of Recombinant Human Deoxyribonuclease (rhDNase) for Aerosol Delivery , 1997, Pharmaceutical Research.

[19]  H. Chan,et al.  Effects of Additives on Heat Denaturation of rhDNase in Solutions , 1996, Pharmaceutical Research.

[20]  H. Chan,et al.  Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers. , 1998, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[21]  J. Patton.  Inhalation delivery of therapeutic peptides and proteins. , 1999, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[22]  C. Wai,et al.  pH-Defining Equilibrium between Water and Supercritical CO2. Influence on SFE of Organics and Metal Chelates , 1995 .

[23]  A. Bertucco,et al.  Production of micronic particles of biocompatible polymer using supercritical carbon dioxide. , 1997, Biotechnology and bioengineering.

[24]  A. Jones,et al.  Atomisation and Sprays: Arthur H. Lefebvre, Hemisphere Publishing Corporation, U.S.A. ISBN 0-89116-603-3 , 1989 .

[25]  A. El-Nimr.  A Standard Method for Determination of Lysozyme Activity Via Controlling the Kinetics of Substrate – Enzyme Interactions , 1985 .

[26]  W. Caughey,et al.  Effects of dimethyl sulfoxide, glycerol, and ethylene glycol on secondary structures of cytochrome c and lysozyme as observed by infrared spectroscopy. , 1995, Journal of pharmaceutical sciences.

[27]  Hak-Kim Chan,et al.  Influence of Particle Size, Air Flow, and Inhaler Device on the Dispersion of Mannitol Powders as Aerosols , 1999, Pharmaceutical Research.

[28]  S. Shire,et al.  Assessment of aerosol delivery systems for recombinant human deoxyribonuclease , 1994 .